A share price of Altimmune Inc [ALT] is currently trading at $6.88, up 1.33%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The ALT shares have gain 9.21% over the last week, with a monthly amount drifted -9.11%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Altimmune Inc [NASDAQ: ALT] stock has seen the most recent analyst activity on April 29, 2024, when Guggenheim downgraded its rating to a Neutral. Previously, Goldman started tracking the stock with Neutral rating on January 24, 2024, and set its price target to $13. On March 22, 2023, downgrade downgraded it’s rating to Neutral and revised its price target to $6 on the stock. Goldman started tracking the stock assigning a Buy rating and suggested a price target of $20 on December 01, 2022. H.C. Wainwright started tracking with a Buy rating for this stock on June 02, 2021, and assigned it a price target of $35. In a note dated February 11, 2021, Guggenheim initiated an Buy rating and provided a target price of $36 on this stock.
Altimmune Inc experienced fluctuations in its stock price throughout the past year between $2.09 and $14.84. Currently, Wall Street analysts expect the stock to reach $23.6 within the next 12 months. Altimmune Inc [NASDAQ: ALT] shares were valued at $6.88 at the most recent close of the market. An investor can expect a potential return of 243.02% based on the average ALT price forecast.
Analyzing the ALT fundamentals
Trailing Twelve Months sales for Altimmune Inc [NASDAQ:ALT] were 0.41M which represents -16.67% decline. Gross Profit Margin for this corporation currently stands at -48.99% with Operating Profit Margin at -237.86%, Pretax Profit Margin comes in at -247.79%, and Net Profit Margin reading is -247.79%. To continue investigating profitability, this company’s Return on Assets is posted at -0.58, Equity is -0.61 and Total Capital is -0.61. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.66 points at the first support level, and at 6.43 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.11, and for the 2nd resistance point, it is at 7.33.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Altimmune Inc [NASDAQ:ALT] is 11.30. Also, the Quick Ratio is 11.30, while the Cash Ratio stands at 3.77. Considering the valuation of this stock, the price to sales ratio is 1192.59, the price to book ratio is 3.20.
Transactions by insiders
Recent insider trading involved Drutz David, Director, that happened on Aug 19 ’24 when 16011.0 shares were sold.
